CNR Institutional Research Information System

GASTALDELLI, AMALIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.497
NA - Nord America 4.572
EU - Europa 1.830
SA - Sud America 1.382
Continente sconosciuto - Info sul continente non disponibili 256
AF - Africa 126
OC - Oceania 21
Totale 15.684
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.272
SG - Singapore 2.998
CN - Cina 1.603
BR - Brasile 1.053
HK - Hong Kong 864
IT - Italia 832
VN - Vietnam 740
FR - Francia 414
BD - Bangladesh 337
KR - Corea 272
JP - Giappone 200
CA - Canada 133
IN - India 114
NL - Olanda 99
DE - Germania 89
AR - Argentina 88
FI - Finlandia 84
GB - Regno Unito 79
CO - Colombia 69
EC - Ecuador 67
MX - Messico 65
ID - Indonesia 57
IL - Israele 37
RU - Federazione Russa 30
ZA - Sudafrica 30
VE - Venezuela 28
SA - Arabia Saudita 27
TR - Turchia 27
PE - Perù 25
MA - Marocco 24
IQ - Iraq 23
MY - Malesia 23
UZ - Uzbekistan 22
PH - Filippine 21
UA - Ucraina 21
CL - Cile 20
ES - Italia 20
AU - Australia 18
CR - Costa Rica 18
PK - Pakistan 17
PL - Polonia 17
PY - Paraguay 17
DZ - Algeria 15
EG - Egitto 15
JO - Giordania 15
IE - Irlanda 14
JM - Giamaica 13
SE - Svezia 13
HN - Honduras 12
AL - Albania 11
AT - Austria 11
RO - Romania 10
TH - Thailandia 10
TN - Tunisia 10
NI - Nicaragua 9
NP - Nepal 9
PT - Portogallo 9
TT - Trinidad e Tobago 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 8
BH - Bahrain 8
BO - Bolivia 8
CH - Svizzera 8
DK - Danimarca 8
GR - Grecia 8
KE - Kenya 8
TW - Taiwan 8
GT - Guatemala 7
NO - Norvegia 7
SV - El Salvador 7
UY - Uruguay 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
KZ - Kazakistan 6
LB - Libano 6
LK - Sri Lanka 6
LT - Lituania 6
BB - Barbados 5
OM - Oman 5
AM - Armenia 4
BS - Bahamas 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
MD - Moldavia 4
RS - Serbia 4
CY - Cipro 3
IR - Iran 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
BE - Belgio 2
BW - Botswana 2
CG - Congo 2
CV - Capo Verde 2
CW - ???statistics.table.value.countryCode.CW??? 2
GA - Gabon 2
HR - Croazia 2
KG - Kirghizistan 2
Totale 15.386
Salva come PNG Salva come JPEG
Città #
Singapore 1.773
Hong Kong 848
Hefei 656
Santa Clara 649
San Jose 483
Ashburn 376
Lauterbourg 344
Beijing 269
Seoul 267
Ho Chi Minh City 256
Los Angeles 207
Hanoi 173
Tokyo 157
Dallas 156
New York 126
São Paulo 95
Buffalo 88
Rome 85
Milan 81
Council Bluffs 76
Chicago 45
Florence 43
Helsinki 43
Cascina 42
Naples 41
Frankfurt am Main 38
Minamishinagawa 36
Rio de Janeiro 35
Atlanta 34
Brooklyn 33
Houston 33
Orem 33
Lappeenranta 32
Da Nang 30
Phoenix 30
Toronto 30
Haiphong 29
Guangzhou 27
Philadelphia 26
Denver 25
Montreal 25
Quito 24
Belo Horizonte 22
Biên Hòa 22
Newark 22
Bengaluru 21
Guayaquil 20
Tashkent 20
Bologna 19
Brasília 19
Bari 18
Charlotte 18
Curitiba 18
Nuremberg 18
Amsterdam 16
Bogotá 16
Johannesburg 16
Lima 16
Pisa 16
Prato 16
Amman 15
Boston 15
Campinas 15
Queens 15
Boardman 14
Buenos Aires 14
Hải Dương 14
Mexico City 14
Ribeirão Preto 14
San José 14
Dhaka 13
Dublin 13
Figino 13
Fortaleza 13
Shanghai 13
Turin 13
Venice 13
Kuala Lumpur 12
Las Vegas 12
London 12
Miami 12
Salvador 12
Stockholm 12
Memphis 11
Palermo 11
Pittsburgh 11
Porto Alegre 11
Sydney 11
Baghdad 10
Belém 10
Bắc Giang 10
Catania 10
Detroit 10
Lucca 10
Paris 10
St Louis 10
The Bronx 10
Chengdu 9
Istanbul 9
Managua 9
Totale 8.711
Salva come PNG Salva come JPEG
Nome #
Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile 203
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial 189
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 145
Hepatic glucose metabolism in the steatotic liver 130
CISAS-WP4: studi di epidemiologia eziologica nei SIN di Priolo, Milazzo e Crotone. 128
Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk 109
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) 106
F-18-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: A validation study 104
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance 102
Healthy aging: the INTECMAN project 95
ForePass endoscopic bypass device for obesity and insulin resistance—metabolic treatment in a swine model 94
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features 91
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary 89
A minimal model of glucose absorption, production and disappearance for double-tracer oral glucose tolerance tests 84
Long-term effects of bariatric surgery on meal disposal and ss-cell function in diabetic and nondiabetic patients 83
Exposure profiles in pregnant women from a birth cohort in a highly contaminated area of southern Italy 83
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease 82
Changes in plasma bioactive lipids and inflammatory markers during a half-marathon in trained athletes 82
Dodecanedioic acid prevents and reverses metabolic‐associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet‐induced obesity 81
Krill oil supplementation reduces exacerbated hepatic steatosis induced by thermoneutral housing in mice with diet-induced obesity 81
GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss 79
Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars 79
Visceral fat in hypertension - Influence on insulin resistance and beta-cell function 78
The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases 78
The Nonalcoholic Steatohepatitis Metabotype: Imbalance of Circulating Amino Acids and Transamination Reactions Reflect Impaired Mitochondrial Function REPLY 76
Improved unsupervised assessment of abdominal fat in MRI by automatic correction of intensity inhomogeneities 76
Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies 75
Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with NASH 72
Motor Activity in Aging: An Integrated Approach for Better Quality of Life 71
Biomarkers of exposure and early effect in three contaminated sites of southern Italy: Protocols for etiological epidemiological studies 70
Relationship between fatty liver and glucose metabolism: A cross-sectional study in 571 obese children 69
Liver Transplantation Is Associated with an Unfavourable Metabolic Signature 69
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals 69
Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects 69
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH 68
Biomonitoring of Bis(2-ethylhexyl)phthalate (DEHP) in Italian children and adolescents: Data from LIFE PERSUADED project 67
Succinate Modulation as a Biochemical Correlate of Metabolic and Neurobehavioral Changes Associated With Intermittent Fasting in Obesity 66
Increased hepatic glucose production and insulin resistance are associated to increased plasma concentrations of glucogenic amino acids in subjects with NAFLD 66
The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF 65
Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System 65
Mechanism of Action of Inhaled Insulin on Whole Body Glucose Metabolism in Subjects with Type 2 Diabetes Mellitus 64
Lipid metabolism in MASLD and MASH: From mechanism to the clinic 64
Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation 64
Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes 63
Occurrence of diabetes in idiopathic left ventricular dysfunction: Prevalence and relationship with myocardial perfusion and function 63
LACK OF NLRP3-INFLAMMASOME LEADS TO GUT-LIVER AXIS DERANGEMENT AND INCREASES HEPATIC INJURY IN A MOUSE MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE 63
GLP-1 enhances β-cell response to protein ingestion and bariatric surgery amplifies it 63
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P 62
Influence of duration of obesity on the insulin resistance of obese non-diabetic patients 61
Model-based assessment of insulin sensitivity of glucose disposal and endogenous glucose production from double-tracer oral glucose tolerance test 61
EARLY INCREASE IN N(EPSILON)-CARBOXY-METHYL-LYSINE AND DECREASE IN sRAGE PLASMA VALUES IN DE NOVO LIVER TRANSPLANTATION 60
STUDY OF GLUCOSE AND GLYCEROL KINETICS DURING FASTING AND HYPERINSULINEMIA BY COMPARTMENTAL ANALYSIS USING SAAM-II 60
New insights on the interactions between insulin clearance and the main glucose homeostasis mechanisms 60
Advanced glycation end products, leukocyte telomere length, and mitochondrial DNA copy number in patients with coronary artery disease and alterations of glucose homeostasis: From the GENOCOR study 60
Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects 60
From MASTHIA to MAST4HELTH: Report from the Secondment Experience 59
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy 59
Chapter 8. Risk Relationship between Insulin Resistance, Diabetes, and Atherosclerotic Cardiovascular Disease 58
Brain histone beta-hydroxybutyrylation couples metabolism with gene expression 58
Increased FNDC5/Irisin expression in human hepatocellular carcinoma 58
Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response 57
Effects of Mixtures of Emerging Pollutants and Drugs on Modulation of Biomarkers Related to Toxicity, Oxidative Stress, and Cancer 57
Moving medical semeiotics to the digital realm: SEMEOTICONS approach to face signs of cardiometabolic risk 57
Evaluation of published clinical scores for the prediction of cardiometabolic risk in the SEMEOTICONS project 57
Metabolic response to high-carbohydrate and low-carbohydrate meals in a nonhuman primate model 56
Pioglitazone Treatment Increases Whole Body Fat But Not Total Body Water in Patients with on-Alcoholic Steatohepatitis ( ASH) 55
Insulin sensitivity depends on the route of glucose administration 55
Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD 55
Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study 55
Impact of PPAR-gamma agonists on adipose-tissue insulin resistance in patients with IGT or T2DM and non-alcoholic steatohepatitis (NASH) 54
Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study 54
Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis 54
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models 54
Mechanism and Effects of Glucose Absorption during an Oral Glucose Tolerance Test Among Females and Males 54
A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment 53
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease 53
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease 53
EVALUATION OF METABOLIC PARAMETERS OF HEPATIC DYSFUNCTION IN SUBJECTS WITH HEPATOCELLULAR CARCINOMA AND THEIR CHANGE AFTER LIVER TRANSPLANTATION: A METABOLOMIC APPROACH 53
Inflammatory Biomarkers are Correlated with Some Forms of Regressive Autism Spectrum Disorder 52
Why does obesity cause diabetes? 52
Mechanisms for increased risk of diabetes in chronic liver diseases 52
Plasma proteomic signatures of a direct measure of insulin sensitivity in two population cohorts 52
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease 52
Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study 51
Brown versus white fat: are they really playing a role in obesity and cardiometabolic risk? "Brown adipose tissue plays a key role in thermogenesis..." 51
From MASTIHA to MAST4HEALTH: Report from the Secondment Experience 51
EFFECTS OF EXERCISE INTENSITY ON FAT METABOLISM 50
Non alcoholic fatty liver disease: a systemic disease 50
Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver 50
Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial 50
Phthalates exposure as determinant of albuminuria in subjects with type 2 diabetes: A cross-sectional study 50
Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type 2 diabetes 50
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests 50
Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance 50
Effect of obesity on insulin secretion in response to a 48-hour Physiological Increase in plasma FFA in Mexican-American subjects genetically predisposed Type 2 Diabetes 50
Altered metabolic profile and adipocyte insulin resistance mark severe liver fibrosis in patients with chronic liver disease 50
CHANGES IN TRACER INFUSION RATES TO MINIMIZE THE STRUCTURAL ERROR IN STEELES MODEL 49
Decreased whole-body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients 49
Effects of Adding Exercise to a 16-Week Very Low-Calorie Diet in Obese, Insulin-Dependent Type 2 Diabetes Mellitus Patients 49
Influence of hepatic and peripheral insulin resistance on glucose tolerance in non diabetic subjects: the RISC study. 48
Totale 6.902
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.237
article - articoli 53.574
book - libri 130
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 581
Totale 112.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202458 0 0 0 0 0 0 0 0 3 1 42 12
2024/20254.366 19 35 361 231 565 150 138 189 136 139 1.268 1.135
2025/20269.467 411 897 732 1.292 1.376 342 1.407 663 564 581 693 509
2026/20271.793 566 555 672 0 0 0 0 0 0 0 0 0
Totale 15.684